NCT07323862 Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Their Ability to Determine Where a Sound Originates From
| NCT ID | NCT07323862 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Urbana-Champaign |
| Condition | Cochlear Implant Users |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2026-04-27 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2026-04-27 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine if a new algorithm can improve speech perception for cochlear implant users. The main questions it aims to answer \[is/are\]: * Does the algorithm improve speech perception in noisy environments? * Does the algorithm allow listeners to determine where a sound is coming from? Participants will * Listen to and repeat sentences presented in the presence of noise * Indicate the location that sounds originated from
Eligibility Criteria
Inclusion Criteria: * Participants must have bilateral cochlear implants from Cochlear or Advanced Bionics Exclusion Criteria: * Non-native English speakers
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07323862 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cochlear Implant Users. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07323862 currently recruiting?
Yes, NCT07323862 is actively recruiting participants. Contact the research team at jaronoff@illinois.edu for enrollment information.
Where is the NCT07323862 trial being conducted?
This trial is being conducted at Champaign, United States.
Who is sponsoring the NCT07323862 clinical trial?
NCT07323862 is sponsored by University of Illinois at Urbana-Champaign. The trial plans to enroll 25 participants.